Menu
Solution
Turnkey Multidisciplinary Cancer (MDC) Care Solution
Advanced Tumor Board/MDT Management
Network and Referral Expansion
Patient Tracking, Quality and Accreditation
Patient Loyalty and Survivorship Planning
Cancer Data Access and Insights
Resources
All Resources
Blog
Case Studies
Education
CME
News
About
About Us
Meet Our Leadership Team
Meet Our Board of Directors
Awards
Contact Us
Careers
Solution
Turnkey Multidisciplinary Cancer (MDC) Care Solution
Advanced Tumor Board/MDT Management
Network and Referral Expansion
Patient Tracking, Quality and Accreditation
Patient Loyalty and Survivorship Planning
Cancer Data Access and Insights
Resources
All Resources
Blog
Case Studies
Education
CME
News
About
About Us
Meet Our Leadership Team
Meet Our Board of Directors
Awards
Contact Us
Careers
SCHEDULE A DEMO
Home
Resources
NSCLC
NSCLC
Non-small cell lung cancer (NSCLC).
Other Topics:
ATM
(2)
BRCA
(2)
Breast Cancer
(2)
cardiovascular
(1)
CDK12
(2)
CoC
(1)
EGFR
(8)
endocrinology
(1)
Exon 19 Deletion
(4)
Gastric Cancer
(3)
gastroenterology
(1)
immunotherapy
(5)
irAE
(5)
KIT Exon 11
(2)
Lung Cancer
(10)
NSCLC
(9)
Ovarian Cancer
(3)
Prostate Cancer
(2)
rheumatology
(1)
TP53
(2)
Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer
Topics —
NSCLC
May 12, 2022
|
CME
Quality Improvement Program Webinar—NSCLC Biomarker Testing
Topics —
NSCLC
Mar 8, 2022
|
Education
Molecular Testing in the Community Oncology Setting
Topics —
Breast Cancer
,
Gastric Cancer
,
Lung Cancer
,
NSCLC
Jun 1, 2021
|
CME
NCCN updates: Stage IB – IIA NSCLC with EGFR Alteration Patients
Topics —
EGFR
,
Exon 19 Deletion
,
Lung Cancer
,
NSCLC
Mar 1, 2021
|
Education
NSCLC Patient and Adjuvant Chemotherapy
Topics —
EGFR
,
Lung Cancer
,
NSCLC
Mar 1, 2021
|
Education
Patient with Possible Synchronous Early-stage NSCLC and Different DetermaRx Results
Topics —
Lung Cancer
,
NSCLC
Feb 1, 2021
|
Education
Patient with NSCLC Who Recurred within a Year
Topics —
EGFR
,
Lung Cancer
,
NSCLC
Feb 1, 2021
|
Education
Patient with Stage IB NSCLC, an Oncocyte DetermaRx High-Risk Result and an EGFR Exon 19 Deletion
Topics —
EGFR
,
Exon 19 Deletion
,
Lung Cancer
,
NSCLC
Feb 1, 2021
|
Education
Stratification of Early-Stage, Non-squamous NSCLC Patients Likely to Benefit from Early, Post-operative Chemotherapy
Topics —
EGFR
,
Exon 19 Deletion
,
Lung Cancer
,
NSCLC
Feb 1, 2021
|
Education